Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a subgroup of breast cancer that is negative for estrogen and progesterone receptor and ERBB2 protein expression. It is characterized by its aggressive behavior and by the lack of targeted therapies. To identify new therapeutic targets in TNBC, we used real-ti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Glénisson, Mathilde, Vacher, Sophie, Callens, Céline, Susini, Aurélie, Cizeron-Clairac, Géraldine, Le Scodan, Romuald, Meseure, Didier, Lerebours, Florence, Spyratos, Frédérique, Lidereau, Rosette, Bièche, Ivan
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2012
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3415670/
https://ncbi.nlm.nih.gov/pubmed/22893791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601912449832
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares